The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy

Recent work suggests the selective Cox-2 inhibitor celecoxib delays progression to androgen independence in hormone sensitive prostate cancer (HSPC) through inhibition of the androgen receptor (AR) and ErbB signaling. However, human studies examining its effect on delaying disease progression while...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am J Clin Exp Urol
Main Authors: Etheridge, Tyler, Liou, Jinning, Downs, Tracy M, Abel, E Jason, Richards, Kyle A, Jarrard, David F
Format: Artigo
Sprog:Inglês
Udgivet: e-Century Publishing Corporation 2018
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6055075/
https://ncbi.nlm.nih.gov/pubmed/30038944
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker